This marks the third attempt by Ukraine’s largest mobile operator to acquire MTPK LLC, the legal entity that owns the Tabletki.ua brand. The company submitted its first application in November 2024 and the second in February 2025, but both were rejected by the regulator.
Kyivstar filed its third application on 7 July 2025, although it has not yet been placed on the AMCU’s agenda. Sources cited by Forbes Ukraine note that the process is complicated by differing interpretations of market size and participant market shares. Helsi, a service 98% owned by Kyivstar, also offers a medicine booking function, raising regulatory concerns about potential market concentration.
Tabletki.ua is one of Ukraine’s largest pharmaceutical aggregators, serving around 10 million users per month. In 2024, MTPK LLC generated revenue of UAH 715 million, nearly double its 2023 result. The platform partners with more than 12,000 pharmacies, representing about 70% of the country’s pharmacy retail market, and earns revenue through a 2% commission on each transaction.
Market discussions previously suggested a deal valuation ranging from $30 million to $80 million, with around $60 million cited during preliminary negotiations. Changes in the regulatory environment — including legislation aimed at lowering drug prices and capping pharmacy markups — have also affected the company’s valuation.
Experts note that acquiring Tabletki.ua would be an important step for Kyivstar in building a transparent digital pharmaceutical ecosystem. Integrating the platform’s data with Kyivstar’s analytics could improve demand monitoring for medicines and enable the introduction of innovative market solutions.
Sources close to the deal told Forbes Ukraine that the transaction is likely to be successfully completed in early autumn 2025.
